-
1دورية أكاديمية
المؤلفون: Janku, Filip, Choong, Grace M, Opyrchal, Mateusz, Dowlati, Afshin, Hierro, Cinta, Rodon, Jordi, Wicki, Andreas, Forster, Martin D, Blagden, Sarah P, Yin, Jun, Reid, Joel M, Muller, Helene, Cmiljanovic, Natasa, Cmiljanovic, Vladimir, Adjei, Alex A
المصدر: Cancers , 16 (6) , Article 1137. (2024)
مصطلحات موضوعية: PI3K/mTOR inhibitor, clinical trial, solid tumor, safety, intermittent dosing schedule
وصف الملف: text
العلاقة: https://discovery.ucl.ac.uk/id/eprint/10190777/1/cancers-16-01137-v3.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10190777Test/
-
2دورية أكاديمية
المؤلفون: Filip Janku, Grace M. Choong, Mateusz Opyrchal, Afshin Dowlati, Cinta Hierro, Jordi Rodon, Andreas Wicki, Martin D. Forster, Sarah P. Blagden, Jun Yin, Joel M. Reid, Helene Muller, Natasa Cmiljanovic, Vladimir Cmiljanovic, Alex A. Adjei
المصدر: Cancers, Vol 16, Iss 6, p 1137 (2024)
مصطلحات موضوعية: PI3K/mTOR inhibitor, clinical trial, solid tumor, safety, intermittent dosing schedule, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Antonino Glaviano, Aaron S. C. Foo, Hiu Y. Lam, Kenneth C. H. Yap, William Jacot, Robert H. Jones, Huiyan Eng, Madhumathy G. Nair, Pooyan Makvandi, Birgit Geoerger, Matthew H. Kulke, Richard D. Baird, Jyothi S. Prabhu, Daniela Carbone, Camilla Pecoraro, Daniel B. L. Teh, Gautam Sethi, Vincenzo Cavalieri, Kevin H. Lin, Nathalie R. Javidi‑Sharifi, Eneda Toska, Matthew S. Davids, Jennifer R. Brown, Patrizia Diana, Justin Stebbing, David A. Fruman, Alan P. Kumar
المساهمون: Antonino Glaviano, Aaron S. C. Foo, Hiu Y. Lam, Kenneth C. H. Yap, William Jacot, Robert H. Jone, Huiyan Eng, Madhumathy G. Nair, Pooyan Makvandi, Birgit Geoerger, Matthew H. Kulke, Richard D. Baird, Jyothi S. Prabhu, Daniela Carbone, Camilla Pecoraro, Daniel B. L. Teh, Gautam Sethi, Vincenzo Cavalieri, Kevin H. Lin, Nathalie R. Javidi‑Sharifi, Eneda Toska, Matthew S. David, Jennifer R. Brown, Patrizia Diana, Justin Stebbing, David A. Fruman, Alan P. Kumar
مصطلحات موضوعية: PI3K/AKT/mTORC pathway, Pan PI3K inhibitor, Isoform-specific PI3K inhibitor, Dual PI3K/mTOR inhibitor, AKT inhibitor, Allosteric mTOR inhibitor, ATP-competitive mTOR inhibitor, Bi-steric mTOR inhibitor, PDK1 inhibitor, Cancer
العلاقة: volume:22; issue:1; numberofpages:37; journal:MOLECULAR CANCER; https://hdl.handle.net/10447/604813Test
-
4دورية أكاديمية
المؤلفون: Shan Xu, Xin Sun, Leixuan Luo, Yang Yang, Qiuyan Guo, Sheng Tang, Zhiyan Jiang, Yuzhen Li, Jiaqian Han, Wenhui Gan, Feiyi Yang, Xuan Zhang, Yijun Liu, Chuanchuan Sun, Jie He, Meng Liu, Daiying Zuo, Wufu Zhu, Yingliang Wu
المصدر: Biomedicine & Pharmacotherapy, Vol 155, Iss , Pp 113537- (2022)
مصطلحات موضوعية: Breast cancer, TNBC, PI3K/mTOR inhibitor, XS-2, In vitro and in vivo antitumor activity, Antitumor mechanism, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S075333222200926XTest; https://doaj.org/toc/0753-3322Test
-
5دورية أكاديمية
المؤلفون: Shaheenah Dawood, Maria Konstantionva, Rebecca Dent, Florencia Perazzo, Sung-Bae Kim, Cynthia Villarreal-Garza, Sandra Franco, Ming-Shen Dai, Sergio Simon
المصدر: BMC Proceedings, Vol 15, Iss S10, Pp 1-17 (2021)
مصطلحات موضوعية: Cyclin-dependent kinase 4/6 inhibitor, Endocrine therapy, Hormone receptor-positive, Human epidermal growth factor receptor 2 negative, Metastatic breast cancer PI3K/mTOR inhibitor, Registry, Medicine, Science
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1753-6561Test
-
6دورية أكاديمية
المصدر: Drug Design, Development and Therapy, Vol Volume 15, Pp 531-542 (2021)
مصطلحات موضوعية: minimally invasive cancer treatment strategy, sonosensitizer, pi3k/mtor inhibitor, ir820 nanobubbles, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
7دورية أكاديمية
المؤلفون: I-Lun Hsin, Huang-Pin Shen, Hui-Yi Chang, Jiunn-Liang Ko, Po-Hui Wang
المصدر: Cells; Volume 10; Issue 11; Pages: 2916
مصطلحات موضوعية: c-Myc, endometrial cancer, mutant p53, dual PI3K/mTOR inhibitor, PQR309
وصف الملف: application/pdf
العلاقة: Cell Proliferation and Division; https://dx.doi.org/10.3390/cells10112916Test
-
8دورية أكاديمية
المؤلفون: Wioleta Justyna Omeljaniuk, Rafał Krętowski, Wioletta Ratajczak-Wrona, Ewa Jabłońska, Marzanna Cechowska-Pasko
المصدر: International Journal of Molecular Sciences; Volume 22; Issue 21; Pages: 11511
مصطلحات موضوعية: apoptosis, glioblastoma, dual PI3K/mTOR inhibitor, GDC-0980, apitolisib
جغرافية الموضوع: agris
وصف الملف: application/pdf
العلاقة: Biochemistry; https://dx.doi.org/10.3390/ijms222111511Test
-
9دورية أكاديمية
المؤلفون: Jilly F. Evans, Ryan W. Rue, Alexander R. Mukhitov, Kseniya Obraztsova, Carly J. Smith, Vera P. Krymskaya
المصدر: Biomolecules; Volume 10; Issue 1; Pages: 28
مصطلحات موضوعية: lymphangioleiomyomatosis (LAM), TSC2-null, rapamycin, S6K/S6, 4E-BP1/eIF4E, MNK1/2 inhibitor, PI3k/mTOR inhibitor
جغرافية الموضوع: agris
وصف الملف: application/pdf
العلاقة: Molecular Medicine; https://dx.doi.org/10.3390/biom10010028Test
-
10دورية أكاديمية
المؤلفون: Cretella, Daniele, Ravelli, Andrea, Fumarola, Claudia, La Monica, Silvia, Digiacomo, Graziana, Cavazzoni, Andrea, Alfieri, Roberta, Biondi, Alessandra, Generali, Daniele, Bonelli, Mara, Petronini, Pier Giorgio
المساهمون: Cretella, Daniele, Ravelli, Andrea, Fumarola, Claudia, La Monica, Silvia, Digiacomo, Graziana, Cavazzoni, Andrea, Alfieri, Roberta, Biondi, Alessandra, Generali, Daniele, Bonelli, Mara, Petronini, Pier Giorgio
مصطلحات موضوعية: CDK4/6 inhibition, Glucose metabolism, Palbociclib, PI3K/mTOR inhibitor, Triple-negative breast cancer, Oncology, Cancer Research
وصف الملف: ELETTRONICO
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29587820; info:eu-repo/semantics/altIdentifier/wos/WOS:000428516300006; volume:37; issue:1; firstpage:"-"; lastpage:"-"; numberofpages:12; journal:JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH; http://hdl.handle.net/11368/2935420Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85044545269; https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-0741-3Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872523Test/
الإتاحة: https://doi.org/10.1186/s13046-018-0741-3Test
http://hdl.handle.net/11368/2935420Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872523Test/